Identification of BBOX1 as a Therapeutic Target in Triple-Negative Breast Cancer

[unable to retrieve full-text content]

Triple-negative breast cancer (TNBC) is a highly heterogeneous and clinically aggressive disease that accounts for 15% to 20% of breast cancers, …
Published at Tue, 03 Nov 2020 03:25:29 +0000